VANCOUVER, BC, June 15, 2021 / PRNewswire / – MYND Life Sciences Inc. (CSE: IMAGE) (“PICTURE“) a drug analysis and improvement firm centered on the event of latest psychedelic medication, diagnostic approaches, and prescription drugs, is happy to announce that CEO Dr. Lyle oberg, can be offered on the “Psychedelics in Psychiatry and Past” convention sponsored by HC Wainwright & Co.
The convention can be held just about on Thursday, June 17, 2021. Dr. Oberg will present an outline of MYND’s enterprise, mental property holdings, and its path to novel diagnostics and drug innovation to deal with and diagnose melancholy and different neuroinflammatory ailments.
The main points of the presentation are as follows:
For extra info and to subscribe to the Firm’s mailing checklist, go to https://myndsciences.com/contact/
ABOUT MYND LIFE SCIENCES
MYND Life Sciences is a psychedelic medication biotechnology firm centered on the event of neuropharmaceutical medication. The Firm is selling medication of psychedelic origin primarily based on neuroinflammatory substances by way of rigorous medical and scientific trials with an preliminary concentrate on main depressive dysfunction.
Dr. Lyle oberg, CEO
E-mail: [email protected]
This press launch accommodates forward-looking statements and data throughout the which means of relevant securities regulation. Typically, however not all the time, forward-looking statements and data will be recognized by way of phrases resembling “plans”, “expects” or “doesn’t count on”, “anticipated”, “estimates”, “intends”, “anticipates” or “don’t anticipate”, or “imagine”, or variations of such phrases and phrases or state that sure actions, occasions or outcomes “might”, “might”, “might”, “might” or “can be” taken, happen or be achieved. Ahead-looking statements or info contain recognized and unknown dangers, uncertainties and different components that will trigger MYND’s precise outcomes, efficiency or achievements to be materially completely different from any future outcomes, efficiency or achievements expressed or implied within the forward-looking statements or info. contained on this press launch.
Dangers, uncertainties and different components associated to forward-looking info might trigger precise occasions, outcomes, efficiency, prospects and alternatives to vary materially from these expressed or implied in such forward-looking info. The Canadian Inventory Alternate has not reviewed and doesn’t settle for accountability for the adequacy or accuracy of the content material of this press launch.
SOURCE Mynd Life Sciences Inc.